Document Detail


Modifying quinolone antibiotics yields new anxiolytics.
MedLine Citation:
PMID:  14647497     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Patients taking fluoroquinolone antibiotics such as norfloxacin exhibit a low incidence of convulsions and anxiety. These side effects probably result from antagonism of the neurotransmitter gamma-aminobutyric acid (GABA) at the brain GABA(A) receptor complex (GRC). Modification of norfloxacin yields molecules such as compound 4 that potentiate GABA action with alpha(2) subunit selectivity. Compound 4 is anxiolytic but does not cause sedation, and may represent a new class of ligands that have anxiolytic activity without sedative liability.
Authors:
Timothy B C Johnstone; Derk J Hogenkamp; Leanne Coyne; Jiping Su; Robert F Halliwell; Minhtam B Tran; Ryan F Yoshimura; Wen-Yen Li; Jeff Wang; Kelvin W Gee
Related Documents :
3689367 - Butryic acid analogues augment gamma globin gene expression in neonatal erythroid proge...
19966457 - A novel catalytic ability of gamma-glutamylcysteine synthetase of escherichia coli and ...
12742517 - Potentiation of metabotropic gabab receptors by l-amino acids and dipeptides in rat neo...
11273597 - Surface reconstruction and the difference in surface acidity between gamma- and eta-alu...
15882857 - Structure of the o-specific polysaccharide from shewanella japonica type strain kmm 329...
16496217 - Fluorimetric determination of cerium(iv) with ascorbic acid.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.     Date:  2003-11-30
Journal Detail:
Title:  Nature medicine     Volume:  10     ISSN:  1078-8956     ISO Abbreviation:  Nat. Med.     Publication Date:  2004 Jan 
Date Detail:
Created Date:  2004-01-02     Completed Date:  2004-04-09     Revised Date:  2007-11-14    
Medline Journal Info:
Nlm Unique ID:  9502015     Medline TA:  Nat Med     Country:  United States    
Other Details:
Languages:  eng     Pagination:  31-2     Citation Subset:  IM    
Affiliation:
Department of Pharmacology, College of Medicine, University of California, Irvine, California 92697, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Anti-Anxiety Agents / chemistry,  metabolism,  pharmacology*
Anti-Infective Agents / chemistry,  metabolism,  pharmacology*
Fluoroquinolones / chemistry,  metabolism,  pharmacology*
Humans
Protein Binding
Receptors, GABA-A / metabolism
Recombinant Proteins / metabolism
gamma-Aminobutyric Acid / metabolism
Grant Support
ID/Acronym/Agency:
MH60527/MH/NIMH NIH HHS
Chemical
Reg. No./Substance:
0/Anti-Anxiety Agents; 0/Anti-Infective Agents; 0/Fluoroquinolones; 0/Receptors, GABA-A; 0/Recombinant Proteins; 56-12-2/gamma-Aminobutyric Acid

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Homeostatic proliferation is a barrier to transplantation tolerance.
Next Document:  The promises and pitfalls of reboxetine.